Table 3. Complications and outcomes among patients with DVI with and without AKI.
| Parameters‡ | Overall patients N = 1,484 |
Non-AKI N = 1,413 |
AKI N = 71 |
P-value |
|---|---|---|---|---|
| Complications | ||||
| Severe thrombocytopenia | 873 (58.8) | 820 (58.0) | 53 (74.6) | 0.006** |
| Hypoalbuminemia (N = 1,069) | 190 (17.8) | 158 (15.7) | 32 (52.5) | <0.001** |
| Severe transaminitis (N = 1,415) | 231 (16.3) | 204 (15.1) | 27 (40.3) | <0.001** |
| Coagulopathy (N = 371) | 164 (44.2) | 132 (40.1) | 32 (76.2) | <0.001** |
| Rhabdomyolysis (N = 282) | 15 (5.3) | 10 (4.0) | 5 (15.6) | 0.018* |
| Shock | 17 (1.1) | 6 (0.4) | 11 (15.6) | <0.001* |
| Coexisting bacterial infection | 51 (3.4) | 36 (2.5) | 15 (21.1) | <0.001* |
| Respiratory failure | 11 (0.7) | 0 (0) | 11 (15.5) | N/A |
| Metabolic acidosis | 41 (3.0) | 24 (1.8) | 17 (24.3) | <0.001* |
| Major bleeding | 27 (1.8) | 22 (1.6) | 5 (7.0) | 0.008* |
| Encephalopathy | 6 (0.4) | 1 (0.1) | 5 (7.0) | <0.001* |
| Myocarditis | 5 (0.3) | 3 (0.2) | 2 (2.8) | 0.021* |
| DIC | 7 (0.5) | 0 (0) | 7 (9.9) | N/A |
| Multi-organ failure | 13 (0.9) | 1 (0.1) | 12 (16.9) | <0.001* |
| Outcome | ||||
| Dialysis | 10 (0.7) | 0 (0) | 10 (14.1) | N/A |
| Hospitalization >3 days | 671 (45.2) | 627 (44.4) | 44 (62.0) | 0.005** |
| Use of vasopressors | 11 (0.7) | 2 (0.1) | 9 (12.7) | <0.001* |
| Recovery | 1,475 (99.4) | 1,413 (100) | 62 (87.3) | <0.001* |
| Death | 9 (0.6) | 0 (0) | 9 (12.7) | N/A |
DIC: disseminated intravascular coagulation
‡Frequency (%)
*Fisher’s exact test
**chi-square test